Methods for determining hazard ratio for in-hospital mortality amongst hospitalized COVID-19 patients in New York City given Azithromycin, Hydroxychloroquine, or a combination
- Sample selection
- Data collection
- Data/variables of interest
- Statistical analysis
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Learn After
Data collection for evaluating outcomes in hospitalized COVID-19 patients in New York City given Azithromycin, Hydrochloroquine, or a combination
Sample selection for evaluating outcomes in hospitalized COVID-19 patients in New York City given Azithromycin, Hydroxychloroquine, or a combination
Data/variables of interest for evaluating outcomes in hospitalized COVID-19 patients in New York City given Azithromycin, Hydroxychloroquine, or a combination
Learn After
Data collection for evaluating outcomes in hospitalized COVID-19 patients in New York City given Azithromycin, Hydrochloroquine, or a combination
Sample selection for evaluating outcomes in hospitalized COVID-19 patients in New York City given Azithromycin, Hydroxychloroquine, or a combination
Data/variables of interest for evaluating outcomes in hospitalized COVID-19 patients in New York City given Azithromycin, Hydroxychloroquine, or a combination